Brief: Frequency Therapeutics Reports Q3 Loss Per Share $0.16
Nov 16 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* FREQUENCY THERAPEUTICS PROVIDES BUSINESS UPDATES AND
REPORTS
THIRD QUARTER 2020 FINANCIAL RESULTS
* COMPANY ENDS QUARTER WITH $224.2M IN CASH, CASH
EQUIVALENTS AND
SHORT-TERM INVESTMENTS
* QTRLY LOSS PER SHARE $0.16
* QTRLY REVENUE $11.2 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.28, REVENUE VIEW $5.9
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw4BD2hVa
Further company coverage: FREQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview